Altimmune Inc
ALT
$2.33+0.65%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$527.02M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$41,000
EPS (TTM)
$-1.02
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-214860.98%
Beta
0.23
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Latest reported ALT revenue for 2025-12-31 was $41.0K. Net income was -$88.1M. Revenue was up 105.0% from 2024-12-31 to 2025-12-31. ALT currently screens at market cap $527.0M.
Use this ALT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALT income, balance, and cash tables.
Altimmune Inc (ALT) is a biotechnology company in the Healthcare sector.
Latest cached Altimmune Inc (ALT) revenue for Dec 31, 2025 was $41.0K. Net income was -$88.1M. Statements: https://lician.com/financials/alt
Altimmune Inc (ALT) market capitalization is $527.0M on the latest cached snapshot.
Altimmune Inc (ALT) cached previous close $2.31; day range $2.31 – $2.33; volume 2,294,825. Session quote: https://lician.com/quote/alt